AstraZeneca Moves Low-Carbon Inhaler Closer to EU Approval
AstraZeneca has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for Trixeo Aerosphere using a next-generation propellant with near-zero Global Warming Potential (GWP). The decision supports the company's plans to reduce the carbon footprint of its respiratory medicines while maintaining treatment for patients with chronic obstructive pulmonary disease (COPD).
“Healthcare Professionals are Looking for Specialist Events That Understand Their World” : Q&A with Paula Jurvanen, M&I Healthcare
We speak with Paula Jurvanen, Managing Director at global events organisation M&I Forums, about the evolving healthcare and life sciences meetings sector, the importance of specialist communities, and how the organisation is shaping the future of compliant, high-value industry events.
Philips Future Health Index 2026: AI Reshapes Frontline Care in the UK as Healthcare Readiness Gaps Remain
Philips’ Future Health Index 2026 report finds artificial intelligence (AI) is already helping UK healthcare professionals save time, increase patient capacity and support clinical decision-making, but highlights ongoing challenges around training, governance and workplace readiness.
Johnson & Johnson to Invest More Than USD$1 Billion in U.S. Vision Manufacturing Expansion in Jacksonville, Florida
Johnson & Johnson is investing more than USD$1 billion to expand its Jacksonville Vision manufacturing operations, adding advanced production, packaging, and distribution capacity to strengthen U.S. supply chain resilience and support demand for ACUVUE® contact lenses used by more than 40 million patients globally.
DHL’s Automated Healthcare Hub Signals the Future of UK Life Sciences Supply Chains
DHL Supply Chain is investing in a new automated healthcare logistics hub at Infinity Park Derby, combining shared-user warehousing, multi-temperature capabilities and sustainability-led design. The facility reflects how healthcare supply chains are evolving to meet growing demand for pharmaceuticals, medical devices and consumer health products through greater resilience, scalability and automation.
Heidi : Moving AI in General Practice from Burden to Genuine Digital Relief
Dr Hannah Allen, practising GP and Chief Medical Officer at Heidi – a digital artificial intelligence (AI) care partner – provides key insights into what safety-first AI in healthcare looks like in practice.
Haleon Expands Rural Health Access in India with £175 Million Manufacturing and Distribution Investment
New Haleon manufacturing facility and expanded community outreach aim to improve oral health access for more than 300 million additional consumers.
NHS England Embraces AI With the Roll-out of Microsoft 365 Copilot
Microsoft 365 Copilot is set to support 500,000 clinicians and support staff as NHS England accelerates artificial intelligence adoption across healthcare services.
Google Breaks Ground on Swedish Data Centre
Google is breaking ground in Sweden with the construction of a cutting-edge data centre in Horndal, designed not only to enhance its digital services but also to foster community growth and sustainable practices through significant investments and job creation.
Houlihan Lokey : Why the Next Decade of MedTech Belongs to Infrastructure
Paul Tomasic, Managing Director and Head of European Healthcare at Houlihan Lokey, outlines why the sector’s financial prize has shifted from hardware to the underlying digital and physical plumbing of healthcare.
HSBC Innovation Banking Life Sciences’ UK & Europe
Following the release of HSBC Innovation Banking Life Sciences’ UK & Europe: Life Sciences & Healthcare Venture Financing Report for FY25, we sit down with Paula Burke, Director, HealthTech and Medical Devices, and Dominick Kennerson, Director, Business Development, Life Sciences and Healthcare.
Medicines for Malaria Venture : Ending Malaria, Rewriting the Future
Medicines for Malaria Venture is continuing to innovate its R&D pipeline, collaborate with stakeholders, and refine its product development partnership model. Dr Martin Fitchet, CEO, tells us more.
